Skip to main content

Acute Intracranial Hemorrhage clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for
  • Trial of Andexanet Alfa in ICH Patients Receiving an Oral FXa Inhibitor

    open to eligible people ages 18 years and up

    Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet alfa versus usual standard of care in patients with intracranial hemorrhage anticoagulated with a direct oral anticoagulant

    Orange, California and other locations

Last updated: